Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Protein Trafficking Vesicle Transport SNAPs & SNAREs

Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR12790] to VAMP2 - BSA and Azide free
  • Suitable for: ICC, Flow Cyt (Intra), WB, IP
  • Reacts with: Mouse, Rat, Human

You may also be interested in

Product image
Recombinant Human CPLX1 protein (ab79148)
Product image
Anti-YKT6 antibody (ab241382)
Product image
Anti-Syntaxin antibody [EPR15139(B)] (ab188583)
Product image
Recombinant Human Syntaxin 3 protein (ab124597)

Overview

  • Product name

    Anti-VAMP2 antibody [EPR12790] - BSA and Azide free
    See all VAMP2 primary antibodies
  • Description

    Rabbit monoclonal [EPR12790] to VAMP2 - BSA and Azide free
  • Host species

    Rabbit
  • Tested applications

    Suitable for: ICC, Flow Cyt (Intra), WB, IPmore details
  • Species reactivity

    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB: Human fetal brain and Human cerebellum lysates ICC/IF: SH-SY5Y cells. Flow Cyt (intra): Jurkat cells.
  • General notes

    ab214590 is the carrier-free version of ab181869.

    Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.

    This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

    Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with

    This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C. Do Not Freeze.
  • Storage buffer

    pH: 7.2
    Constituent: PBS
  • Carrier free

    Yes
  • Concentration information loading...
  • Purity

    Protein A purified
  • Clonality

    Monoclonal
  • Clone number

    EPR12790
  • Isotype

    IgG
  • Research areas

    • Signal Transduction
    • Protein Trafficking
    • Vesicle Transport
    • SNAPs & SNAREs
    • Neuroscience
    • Cell Type Marker
    • Neuron marker
    • Synapse marker
    • Cancer
    • Cancer Metabolism
    • Metabolic signaling pathway
    • Integration of energy metabolism
    • Metabolism
    • Pathways and Processes
    • Metabolic signaling pathways
    • Energy transfer pathways
    • Integration of energy

Images

  • Immunocytochemistry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
    Immunocytochemistry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

    ab181869 staining VAMP2 in U87-MG (human glioblastoma) cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 100% methanol. Samples were incubated with primary antibody at a dilution of 1/500. A goat anti rabbit IgG (Alexa Fluor® 488) (ab150077) was used as the secondary antibody at a dilution of 1/1000. DAPI was used as a nuclear counterstain.

    Negative control 1:PBS only.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab181869).

  • Immunoprecipitation - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
    Immunoprecipitation - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

    ab181869 (purified) at 1/150 immunoprecipitating VAMP2 in Human cerebellum whole cell lysate. 10 ug of cell lysate was present in the input. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution. A rabbit monoclonal IgG (ab172730) was used intead of ab128913 as a negative control (Lane 3).

    Blocking buffer and concentration: 5% NFDM/TBST.

    Diluting buffer and concentration: 5% NFDM /TBST.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab181869).

  • Flow Cytometry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
    Flow Cytometry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

    Clone EPR12790 (ab214590) has been successfully conjugated by Abcam. This image was generated using Anti-VAMP2 antibody [EPR12790] (PE). Please refer to ab214529 for protocol details.

    Overlay histogram showing U-87MG cells stained with ab214529 (red line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilized with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS / 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (ab214529, 1/2500 dilution) for 30 min at 22°C.

    Isotype control antibody (black line) was Rabbit IgG (monoclonal) Phycoerythrin (ab209478) used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.

    Acquisition of >5,000 events were collected using a 50mW Yellow/Green laser (561nm) and 586/15 bandpass filter.

    This antibody gave a positive signal in U-87MG cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Triton X-100 for 15 min used under the same conditions.

  • Immunocytochemistry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
    Immunocytochemistry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

    Clone EPR12790 (ab214590) has been successfully conjugated by Abcam. This image was generated using Anti-VAMP2 antibody [EPR12790] (Alexa Fluor® 647). Please refer to ab198949 for protocol details.

    ab198949 staining VAMP2 in U87MG cells. The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab198949 at a 1/100 dilution (shown in red) and ab195887, Mouse monoclonal to alpha Tubulin (Alexa Fluor® 488), at a 1/250 dilution (shown in green). Nuclear DNA was labelled with DAPI (shown in blue).

    Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

  • Flow Cytometry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
    Flow Cytometry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

    Flow Cytometry analysis of SH-SY5Y cells labelling VAMP2 with purified ab181869 at 1/100 (red). Cells were fixed with 4% paraformaldehyde. A FITC-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab181869).

  • Immunocytochemistry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
    Immunocytochemistry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

    Immunocytochemistry/Immunofluorescence analysis of U87-MG (human glioblastoma) cells labelling VAMP2 with purified ab181869 at 1/250. Cells were fixed with 100% methanol and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/1000) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000) were also used.

    Control 1: primary antibody (1/100) and secondary antibody, ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/500).

    Control 2: ab7291 (1/1000) and secondary antibody, ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500).

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab181869).

  • Immunoprecipitation - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
    Immunoprecipitation - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

    Western blot analysis of immunoprecipitation pellet from Human cerebellum lysate immunoprecipitated using ab181869 at 1/70 dilution.
    Secondary: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab181869).

  • Flow Cytometry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
    Flow Cytometry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

    Flow cytometry analysis of Jurkat cells fixed with 2% paraformaldehyde labeling VAMP2 with unpurified ab181869 at 1/150 dilution followed by Goat anti rabbit IgG (FITC) at 1/150 dilution. Rabbit monoclonal IgG was used as an isotype control.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab181869).

  • Immunocytochemistry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
    Immunocytochemistry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

    Immunofluorescent analysis of SH-SYSY cells (4% paraformaldehyde-fixed) labeling VAMP2 with unpurified ab181869 at 1/500 dilution followed by Goat anti rabbit IgG (Alexa Fluor®488) at 1/200 dilution and counterstained with DAPI.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab181869).

  • Immunocytochemistry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
    Immunocytochemistry - Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

    Immunofluorescent analysis of U87-MG cells (4% paraformaldehyde-fixed)  labeling VAMP2 with ab181869 at 1/500 dilution followed by Goat anti rabbit IgG (Alexa Fluor®488) at 1/200 dilution and counterstained with Dapi.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab181869).

  • Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)
    Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-VAMP2 antibody [EPR12790] - BSA and Azide free (ab214590)

  •  
  • Product image

    HRP Anti-VAMP2 antibody [EPR12790] (ab198948)

    Applications: WB

  •  
  • Product image

    PE Anti-VAMP2 antibody [EPR12790] (ab214529)

    Applications: Flow Cyt

  •  
  • Product image

    Anti-VAMP2 antibody [EPR20818] (ab215721)

    Applications: IHC-P, IP, WB

  •  
  • Product image

    Anti-VAMP2 antibody [6F9] - N-terminal (ab181754)

    Applications: ICC/IF, WB

  •  
  • Product image

    Anti-VAMP2 antibody (ab3347)

    Applications: WB

  •  
  • Product image

    Anti-VAMP2 antibody (ab228996)

    Applications: ICC/IF, WB

  •  
  • Product image

    Alexa Fluor® 647 Anti-VAMP2 antibody [EPR12790] (ab198949)

    Applications: Flow Cyt, ICC/IF

  •  
  • Product image

    Anti-VAMP2 antibody [EPR20818] - BSA and Azide free (ab226863)

    Applications: IHC-P, IP, WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Human IgG Fab fragment antibody [4A11] (ab771)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.